NDLI: Antithrombotics in heart failure with reduced ejection fraction and normal sinus rhythm: an evidence appraisal.

Please wait, while we are loading the content...

Dual intraventricular plus systemic antibiotic therapy for the treatment of Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae ventriculitis.

A review of the pathophysiology, etiology, and treatment of attention-deficit hyperactivity disorder (ADHD).

Assessment and revision of clinical pharmacy practice internet web sites.

Antithrombotics in heart failure with reduced ejection fraction and normal sinus rhythm: an evidence appraisal.

Intravenous warfarin and heparin-induced thrombocytopenia: making the diagnosis, management, modern monitoring, and multidisciplinary care.

Biologics for the treatment of dyslipidemias: a look beyond conventional therapy.

Pharmacists need recognition as providers to enhance patient care.

Drug-drug interaction between methotrexate and levetiracetam resulting in delayed methotrexate elimination.

Predictors of completeness of patients' self-reported personal medication lists and discrepancies with clinic medication lists.

External validation of the medication taper complexity score for methadone tapers in children with opioid abstinence syndrome.

Impact of pharmacist-conducted medication reconciliation at discharge on readmissions of elderly patients with COPD.

Medication therapy management and complex patients with disability: a randomized controlled trial.

Comparative pharmacokinetics and pharmacodynamics of doripenem and meropenem in obese patients.

Combination of fluticasone furoate and vilanterol for the treatment of chronic obstructive pulmonary disease.

Plasma renin activity testing to guide triple antirenin system drug therapy in a patient with difficult-to-treat hypertension.

Severe hypokalemia probably associated with sertraline use.

Assessment of drug-induced torsade de pointes risk for hospitalized high-risk patients receiving QT-prolonging agents.

Year: 2014 Volume: 48 Issue: 1

Year: 2013 Volume: 47

Year: 2012 Volume: 46

Year: 2011 Volume: 45

Year: 2010 Volume: 44

Year: 2009 Volume: 43

Year: 2008 Volume: 42

Year: 2007 Volume: 41

Year: 2003 Volume: 37

Antithrombotics in heart failure with reduced ejection fraction and normal sinus rhythm: an evidence appraisal.

Content Provider	World Health Organization (WHO)-Global Index Medicus
Author	Prom, Rathasen Usedom, James E. Dull, Ryan B.
Description	Country affiliation: United States Author Affiliation: Prom R ( Mission Hospitals, Asheville, NC, USA.)
Abstract	OBJECTIVE: To review the thromboembolic risk, pathophysiology associated with the risk, and literature investigating the use of antithrombotics in patients with heart failure with reduced ejection fraction and normal sinus rhythm (HFrEF-NSR). DATA SOURCES: An English language literature search was performed with MEDLINE/PubMed and Embase from January 1950 to October 2013 using the search terms heart failure, HFrEF, systolic heart failure, cardiomyopathy, left ventricular dysfunction, sinus rhythm, thromboembolism, deep vein thrombosis, pulmonary embolism, myocardial infarction, acute coronary syndrome, acute coronary events, coronary artery disease, stroke, and cerebrovascular events to identify relevant articles. References in the retrieved articles were also assessed to identify other important articles. STUDY SELECTION AND DATA ABSTRACTION: All pertinent original studies, reviews, consensus documents, and guidelines were evaluated for inclusion. DATA SYNTHESIS: Patients with HFrEF-NSR may be predisposed to developing thromboembolic events. Studies that have examined the role of antithrombotics (warfarin and/or antiplatelet therapy) for reducing thromboembolic risk have been inconclusive. The WASH and HELAS pilot trials--the only studies with a no-antithrombotics or placebo comparator group--did not find a benefit with antithrombotic therapy but found an increased risk of bleeding with warfarin and of hospitalizations with aspirin. Although the clinical outcome studies (WATCH and WARCEF) suggested that warfarin may reduce stroke risk compared with antiplatelet therapy, the lack of a placebo group and lower-than-projected enrollment prevents definitive conclusions from being made. CONCLUSIONS: Current evidence does not support the routine use of antithrombotics for preventing thromboembolic events in patients with HFrEF-NSR without compelling indications.
File Format	HTM / HTML
ISSN	10600280
Issue Number	2
Volume Number	48
e-ISSN	15426270
Journal	Annals of Pharmacotherapy
Language	English
Publisher	SAGE Publications
Publisher Date	2014-02-01
Publisher Place	United States
Access Restriction	One Nation One Subscription (ONOS)
Subject Keyword	Discipline Pharmaceutical Science Anticoagulants Therapeutic Use Heart Failure Drug Therapy Platelet Aggregation Inhibitors Ventricular Dysfunction, Left Aspirin Physiopathology Humans Thromboembolism Prevention & Control Warfarin Journal Article Review
Content Type	Text
Resource Type	Article
Subject	Pharmacology (medical)

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Bleeding Risk and Antithrombotic Strategy in Patients With Sinus Rhythm and Heart Failure With Reduced Ejection Fraction Treated With Warfarin or Aspirin

Quality of anticoagulation control in preventing adverse events in patients with heart failure in sinus rhythm: Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trial substudy.

Warfarin and aspirin in patients with heart failure and sinus rhythm.

Aspirin and warfarin equally good for stroke patients.

Relationship between degree of left ventricular dysfunction, symptom status, and risk of embolic events in patients with atrial fibrillation and heart failure.

Left Ventricular Ejection Fraction and Risk of Stroke and Cardiac Events in Heart Failure: Data From the Warfarin Versus Aspirin in Reduced Ejection Fraction Trial.

Left atrial minimal volume: association with diastolic dysfunction and heart failure in patients in sinus rhythm or atrial fibrillation with preserved ejection fraction

Evidence based cardiology: prevention of congestive heart failure and management of asymptomatic left ventricular dysfunction.

Uric Acid Predicts Recovery of Left Ventricular Function and Adverse Events in Heart Failure With Reduced Ejection Fraction: Potential Mechanistic Insight From Network Analyses

Antithrombotics in heart failure with reduced ejection fraction and normal sinus rhythm: an evidence appraisal.

Similar Documents

Bleeding Risk and Antithrombotic Strategy in Patients With Sinus Rhythm and Heart Failure With Reduced Ejection Fraction Treated With Warfarin or Aspirin

Quality of anticoagulation control in preventing adverse events in patients with heart failure in sinus rhythm: Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trial substudy.

Warfarin and aspirin in patients with heart failure and sinus rhythm.

Aspirin and warfarin equally good for stroke patients.

Relationship between degree of left ventricular dysfunction, symptom status, and risk of embolic events in patients with atrial fibrillation and heart failure.

Left Ventricular Ejection Fraction and Risk of Stroke and Cardiac Events in Heart Failure: Data From the Warfarin Versus Aspirin in Reduced Ejection Fraction Trial.

Left atrial minimal volume: association with diastolic dysfunction and heart failure in patients in sinus rhythm or atrial fibrillation with preserved ejection fraction

Evidence based cardiology: prevention of congestive heart failure and management of asymptomatic left ventricular dysfunction.

Uric Acid Predicts Recovery of Left Ventricular Function and Adverse Events in Heart Failure With Reduced Ejection Fraction: Potential Mechanistic Insight From Network Analyses

Antithrombotics in heart failure with reduced ejection fraction and normal sinus rhythm: an evidence appraisal.